Frovatriptan Succinate (Generic for Frova)

Introducing Frovatriptan Succinate developed according to the Frova standard—a long-acting 5-HT1 receptor agonist that effectively relieves migraine pain with sustained action by reducing vasodilation and neurogenic inflammation. Experience improved headache control, decreased recurrence, and enhanced quality of life with this advanced, targeted tablet therapy.